Blood, Plasma, Cells, and Other Biological Fluids
Plasma Fractionation and Plasma Protein Products
Methods for the Analysis of Plasma and Plasma Protein Fractions
Albumin
Structure of Albumin
In Vitro Chemical Modification of Albumin
Albumin as a Carrier
Ligand-Binding by Albumin
Purification and Characterization of HSA for Clinical Use
Biological Activity of Albumin
Enzymatic Activity of Albumin
Clinical Use of Albumin
Albumin as Diagnostic/Biomarker
Pharmacokinetics of Albumin
Analytical Methods for Albumin Including Use of Albumin as Standard for Analytical Methods
Albumin as Excipient
Conclusion
References
Plasma Immunoglobulins
Factor VIII and von Willebrand Factor
von Willebrand Factor
Economic Issues Impacting the Hemophilia Business
Conclusions and Future Directions
References
Plasma Proteinase Inhibitors
Antithrombin
α1-Antitrypsin (α1-Antiprotease Inhibitor, SERPINA1)
Heparin Cofactor II (SERPIND1)
α2-Macroglobulin
Tissue Factor Pathway Inhibitor
α2-Antiplasmin
C1-Inhibitor (C1-Esterase Inhibitor)
Plasminogen Activator Inhibitor-1
Protein C Inhibitor (Plasminogen Activator Inhibitor-3)
References
Vitamin K-Dependent Proteins
Miscellaneous Plasma Proteins
Fibrinogen
Fibrin Sealant
Autologous Fibrin Sealant
Fibrinogen and Tissue Soldering
Thrombin and Fibrin Foam
Fibrinogen Plastics
Thrombin
Plasminogen and Plasmin
Butyrylcholinesterase
Fibronectin
References
Biography
Roger L. Lundblad
